"/> Novus Biologicals™ Peptide bloquant d’anticorps ST… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps ST3GAL6

Réf. : BL-RE-085009Réf. fabricant : 18250646 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
10402
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77353. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the carboxy terminus of human ST3gal6.

Points forts

Source

Synthetic

(Accession #: NP_006091) The ST3GAL6 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-085009
Réf. fabricant18250646
Gene ID (Entrez)10402
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77353. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènealpha2,3-sialyltransferase, CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI, EC 2.4.99, EC 2.4.99.-, EC 2.4.99.9, Sialyltransferase 10, SIAT10, ST3 beta-galactoside alpha-2,3-sialyltransferase 6, ST3Gal VI, ST3GalVI, ST3GALVIsialyltransferase 10 (alpha-2,3-sialyltransferase VI), type 2 lactosamine alpha-2,3-sialyltransferase
Symbole de gène(s)ST3GAL6
Type de produitST3GAL6
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the carboxy terminus of human ST3gal6
Une question, une configuration particulière ?
Contactez-nous pour un devis.